Tapewire

Nasdaq · USD

FATE

FATE THERAPEUTICS INC

Export transactions ↓
Tapewire entity
5968
SEC CIK
0001434316
Parsed reports
323

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2018 Filed Dec 14, 2018 21:33 UTC
Nashat AmirDirector
SaleCommon Stock 4,101 $16.78 $68,826.26
Disclosure

SEC source: 0000899243-18-031090 · doc4.xml · nonDerivative · entry 4

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,965,658

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F5 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Special Founders' Fund V, L.P. ("PVPSFF V"). PVM V is the general partner of PVPSFF V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint and McGuire are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVPSFF V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:33 UTC
Nashat AmirDirector
SaleCommon Stock 2,809 $16.78 $47,142.89
Disclosure

SEC source: 0000899243-18-031090 · doc4.xml · nonDerivative · entry 3

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,969,759

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F4 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Founders' Fund V, L.P. ("PVPFF V"). PVM V is the general partner of PVPFF V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint and McGuire are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVPFF V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:33 UTC
Nashat AmirDirector
SaleCommon Stock 7,993 $16.78 $134,144.92
Disclosure

SEC source: 0000899243-18-031090 · doc4.xml · nonDerivative · entry 2

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,972,568

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVPE V"). PVM V is the general partner of PVPE V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint and McGuire are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVPE V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:33 UTC
Nashat AmirDirector
SaleCommon Stock 410,097 $16.78 $6,882,575.93
Disclosure

SEC source: 0000899243-18-031090 · doc4.xml · nonDerivative · entry 1

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,980,561

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners V, L.P. ("PVP V"). Polaris Venture Management Co. V, L.L.C. ("PVM V") is the general partner of PVP V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Jonathan A. Flint ("Flint") and Terrance G. McGuire ("McGuire") are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVP V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 22:14 UTC
Nashat AmirDirector
SaleCommon Stock 796 $16.71 $13,302.51
Disclosure

SEC source: 0000899243-18-030904 · doc4.xml · nonDerivative · entry 4

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,390,658

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F5 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Special Founders' Fund V, L.P. ("PVPSFF V"). PVM V is the general partner of PVPSFF V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint and McGuire are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVPSFF V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 22:14 UTC
Nashat AmirDirector
SaleCommon Stock 546 $16.71 $9,124.59
Disclosure

SEC source: 0000899243-18-030904 · doc4.xml · nonDerivative · entry 3

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,391,454

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F4 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Founders' Fund V, L.P. ("PVPFF V"). PVM V is the general partner of PVPFF V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint and McGuire are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVPFF V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 22:14 UTC
Nashat AmirDirector
SaleCommon Stock 1,552 $16.71 $25,936.56
Disclosure

SEC source: 0000899243-18-030904 · doc4.xml · nonDerivative · entry 2

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,392,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVPE V"). PVM V is the general partner of PVPE V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint and McGuire are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVPE V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 22:14 UTC
Nashat AmirDirector
SaleCommon Stock 79,634 $16.71 $1,330,819.52
Disclosure

SEC source: 0000899243-18-030904 · doc4.xml · nonDerivative · entry 1

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,393,552

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the United States Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners V, L.P. ("PVP V"). Polaris Venture Management Co. V, L.L.C. ("PVM V") is the general partner of PVP V. The Reporting Person, a member of the Issuer's Board of Directors, is a member of PVM V. Each of Jonathan A. Flint ("Flint") and Terrance G. McGuire ("McGuire") are the managing members of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with respect to PVM V, may be deemed to have shared voting and dispositive power over the shares held by PVP V. Each of PVM V, Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
September 25, 2018 Filed Sep 27, 2018 20:23 UTC
Redmile Group, LLCDirector · 10% owner
Green JeremyDirector · 10% owner
PurchaseCommon Stock 3,703,704 $13.50 $50,000,004.00
Disclosure

SEC source: 0001144204-18-051219 · tv503610_form4.xml · nonDerivative · entry 1

Redmile Group, LLC · CIK 0001425738 · Director · 10% owner

Green Jeremy · CIK 0001650527 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 10,359,666

F1 · ownership.nature: These securities are directly owned by certain private investment vehicles and separately managed accounts managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and separately managed accounts. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.nature: Michael Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
July 31, 2018 Filed Aug 2, 2018 10:11 UTC
Redmile Group, LLCDirector · 10% owner
Green JeremyDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $8.93 $0.00
Disclosure

SEC source: 0001144204-18-041516 · tv499947_form-4.xml · derivative · entry 1

Redmile Group, LLC · CIK 0001425738 · Director · 10% owner

Green Jeremy · CIK 0001650527 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2028-07-31

F1 · derivative.exercise_date: The shares subject to the stock option will vest in equal monthly installments during the 36 months following the grant date, subject to Michael Lee's continued service on the Board of Directors of the Issuer through each vesting date.

F2 · ownership.nature: The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC ("Redmile"), in connection with his appointment to the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3 · ownership.nature: The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F4 · ownership.nature: Mr. Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
July 31, 2018 Filed Aug 2, 2018 10:09 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $8.93 $0.00
Disclosure

SEC source: 0001144204-18-041514 · tv499951_form4.xml · derivative · entry 1

Lee Michael Stewart · CIK 0001748010 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2028-07-31

F1 · derivative.exercise_date: The shares subject to the stock option will vest in equal monthly installments during the 36 months following the grant date, subject to Michael Lee's continued service on the Board of Directors of the Issuer through each vesting date.

F2 · ownership.direct: The stock option was granted to Mr. Lee in connection with his appointment to the Board of Directors of the Issuer. Mr. Lee, a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile Group, LLC ("Redmile"). Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3 · ownership.direct: The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F4 · ownership.direct: Mr. Lee was elected to the board of directors of the Issuer as a representative of Redmile. As a result, Redmile and Mr. Green are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
July 18, 2018 Filed Jul 20, 2018 20:04 UTC
Wolchko J ScottDirector · President and CEO
GrantStock Option (right to buy) · Derivative 450,000 Not disclosed Strike: $11.03 Not disclosed
Disclosure

SEC source: 0001209191-18-043451 · doc4.xml · derivative · entry 1

Wolchko J Scott · CIK 0001586893 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2028-07-17

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on August 18, 2018 such that this option is fully exercisable on July 18, 2022.

Read SEC document
July 18, 2018 Filed Aug 3, 2018 20:09 UTC Amendment
Wolchko J ScottDirector · President and CEO
GrantStock Option (right to buy) · Derivative 152,000 Not disclosed Strike: $11.03 Not disclosed
Disclosure

SEC source: 0001209191-18-045267 · doc4a.xml · derivative · entry 1

Wolchko J Scott · CIK 0001586893 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,000

Underlying: Common Stock · 152,000 shares

Expires 2028-07-17

F1 · shares: The number of shares reported on this amended Form 4 reflects the correct number of shares underlying the stock option granted to Mr. Wolchko on July 18, 2018.

F3 · price: Not applicable.

F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on August 18, 2018 such that this option is fully exercisable on July 18, 2022.

F1 · derivative.underlying_shares: The number of shares reported on this amended Form 4 reflects the correct number of shares underlying the stock option granted to Mr. Wolchko on July 18, 2018.

F1 · balance_after: The number of shares reported on this amended Form 4 reflects the correct number of shares underlying the stock option granted to Mr. Wolchko on July 18, 2018.

Read SEC document
May 15, 2018 Filed May 16, 2018 21:28 UTC
ABBOT STEWARTChief Development Officer
Exercise / conversionStock Option (right to buy) · Derivative 18,138 Not disclosed Strike: $6.90 Not disclosed
Disclosure

SEC source: 0001209191-18-030617 · doc4.xml · derivative · entry 4

ABBOT STEWART · CIK 0001655597 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,862

Underlying: Common Stock · 18,138 shares

Expires 2025-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Not applicable.

F3 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on July 13, 2016 and 1/48th of the shares each month thereafter such that this option is fully exercisable on July 13, 2019. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.

Read SEC document
May 15, 2018 Filed May 16, 2018 21:28 UTC
ABBOT STEWARTChief Development Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,916 Not disclosed Strike: $4.89 Not disclosed
Disclosure

SEC source: 0001209191-18-030617 · doc4.xml · derivative · entry 3

ABBOT STEWART · CIK 0001655597 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,084

Underlying: Common Stock · 2,916 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 12, 2015, such that this option is fully exercisable on October 12, 2019, subject to the recipient's continued service relationship with the Issuer. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.

Read SEC document
May 15, 2018 Filed May 16, 2018 21:28 UTC
ABBOT STEWARTChief Development Officer
Exercise / conversionCommon Stock 18,138 $6.90 $125,152.20
Disclosure

SEC source: 0001209191-18-030617 · doc4.xml · nonDerivative · entry 2

ABBOT STEWART · CIK 0001655597 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2018 Filed May 16, 2018 21:28 UTC
ABBOT STEWARTChief Development Officer
Exercise / conversionCommon Stock 2,916 $4.89 $14,259.24
Disclosure

SEC source: 0001209191-18-030617 · doc4.xml · nonDerivative · entry 1

ABBOT STEWART · CIK 0001655597 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 02, 2018 Filed May 4, 2018 20:20 UTC GrantStock Option (right to buy) · Derivative 16,000 Not disclosed Strike: $9.78 Not disclosed
Disclosure

SEC source: 0001209191-18-028109 · doc4.xml · derivative · entry 1

RASTETTER WILLIAM H · CIK 0001205903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2028-05-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2018 Filed May 4, 2018 20:19 UTC
Nashat AmirDirector
GrantStock Option (right to buy) · Derivative 16,000 Not disclosed Strike: $9.78 Not disclosed
Disclosure

SEC source: 0001209191-18-028106 · doc4.xml · derivative · entry 1

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2028-05-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2018 Filed May 4, 2018 20:19 UTC GrantStock Option (right to buy) · Derivative 16,000 Not disclosed Strike: $9.78 Not disclosed
Disclosure

SEC source: 0001209191-18-028103 · doc4.xml · derivative · entry 1

MENDLEIN JOHN · CIK 0001238362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2028-05-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2018 Filed May 4, 2018 20:17 UTC GrantStock Option (right to buy) · Derivative 16,000 Not disclosed Strike: $9.78 Not disclosed
Disclosure

SEC source: 0001209191-18-028101 · doc4.xml · derivative · entry 1

EPSTEIN ROBERT S · CIK 0001252004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2028-05-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2018 Filed May 4, 2018 20:16 UTC GrantStock Option (right to buy) · Derivative 16,000 Not disclosed Strike: $9.78 Not disclosed
Disclosure

SEC source: 0001209191-18-028099 · doc4.xml · derivative · entry 1

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2028-05-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
January 16, 2018 Filed Jan 17, 2018 16:06 UTC
Storgard ChrisChief Medical Officer
GrantStock Option (right to buy) · Derivative 186,000 Not disclosed Strike: $6.55 Not disclosed
Disclosure

SEC source: 0001209191-18-003921 · doc4.xml · derivative · entry 1

Storgard Chris · CIK 0001674703 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,000

Underlying: Common Stock · 186,000 shares

Expires 2028-01-15

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.

Read SEC document
January 16, 2018 Filed Jan 17, 2018 21:08 UTC
Wolchko J ScottDirector · President and CEO
GrantStock Option (right to buy) · Derivative 348,000 Not disclosed Strike: $6.55 Not disclosed
Disclosure

SEC source: 0001209191-18-003925 · doc4.xml · derivative · entry 1

Wolchko J Scott · CIK 0001586893 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,000

Underlying: Common Stock · 348,000 shares

Expires 2028-01-15

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.

Read SEC document
January 16, 2018 Filed Jan 17, 2018 21:06 UTC
TAHL CINDYGeneral Counsel and Secretary
GrantStock Option (right to buy) · Derivative 200,160 Not disclosed Strike: $6.55 Not disclosed
Disclosure

SEC source: 0001209191-18-003923 · doc4.xml · derivative · entry 1

TAHL CINDY · CIK 0001655472 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,160

Underlying: Common Stock · 200,160 shares

Expires 2028-01-15

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.

Read SEC document
January 16, 2018 Filed Jan 17, 2018 21:05 UTC
Shoemaker Daniel DChief Scientific Officer
GrantStock Option (right to buy) · Derivative 186,000 Not disclosed Strike: $6.55 Not disclosed
Disclosure

SEC source: 0001209191-18-003919 · doc4.xml · derivative · entry 1

Shoemaker Daniel D · CIK 0001586892 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,000

Underlying: Common Stock · 186,000 shares

Expires 2028-01-15

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.

Read SEC document
January 16, 2018 Filed Jan 17, 2018 21:05 UTC
ABBOT STEWARTChief Development Officer
GrantStock Option (right to buy) · Derivative 186,000 Not disclosed Strike: $6.55 Not disclosed
Disclosure

SEC source: 0001209191-18-003918 · doc4.xml · derivative · entry 1

ABBOT STEWART · CIK 0001655597 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,000

Underlying: Common Stock · 186,000 shares

Expires 2028-01-15

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.

Read SEC document
October 16, 2017 Filed Oct 17, 2017 20:05 UTC
Wolchko J ScottDirector · President and CEO
SaleCommon Stock 800 $4.07 $3,256.00
Disclosure

SEC source: 0001209191-17-057149 · doc4.xml · nonDerivative · entry 2

Wolchko J Scott · CIK 0001586893 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,881

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 43,125 shares of Common Stock underlying restricted stock units ("RSUs") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.98 to $4.16 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions.

Read SEC document
October 16, 2017 Filed Oct 17, 2017 20:04 UTC
TAHL CINDYGeneral Counsel and Secretary
SaleCommon Stock 500 $4.10 $2,050.00
Disclosure

SEC source: 0001209191-17-057148 · doc4.xml · nonDerivative · entry 2

TAHL CINDY · CIK 0001655472 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,418

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 20,000 shares of Common Stock underlying restricted stock units ("RSUs") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.99 to $4.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions.

Read SEC document
October 16, 2017 Filed Oct 17, 2017 20:04 UTC
Shoemaker Daniel DChief Scientific Officer
SaleCommon Stock 700 $4.08 $2,856.00
Disclosure

SEC source: 0001209191-17-057147 · doc4.xml · nonDerivative · entry 2

Shoemaker Daniel D · CIK 0001586892 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,591

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 33,000 shares of Common Stock underlying restricted stock units ("RSUs") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover"transaction and does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions.

Read SEC document
October 13, 2017 Filed Oct 17, 2017 20:05 UTC
Wolchko J ScottDirector · President and CEO
SaleCommon Stock 16,368 $3.87 $63,344.16
Disclosure

SEC source: 0001209191-17-057149 · doc4.xml · nonDerivative · entry 1

Wolchko J Scott · CIK 0001586893 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,681

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 43,125 shares of Common Stock underlying restricted stock units ("RSUs") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.53 to $4.08 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions.

Read SEC document
October 13, 2017 Filed Oct 17, 2017 20:04 UTC
TAHL CINDYGeneral Counsel and Secretary
SaleCommon Stock 7,591 $3.83 $29,073.53
Disclosure

SEC source: 0001209191-17-057148 · doc4.xml · nonDerivative · entry 1

TAHL CINDY · CIK 0001655472 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,918

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 20,000 shares of Common Stock underlying restricted stock units ("RSUs") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.08 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions.

Read SEC document
October 13, 2017 Filed Oct 17, 2017 20:04 UTC
Shoemaker Daniel DChief Scientific Officer
SaleCommon Stock 12,525 $3.86 $48,346.50
Disclosure

SEC source: 0001209191-17-057147 · doc4.xml · nonDerivative · entry 1

Shoemaker Daniel D · CIK 0001586892 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,291

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 33,000 shares of Common Stock underlying restricted stock units ("RSUs") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover"transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.08 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions.

Read SEC document
May 02, 2017 Filed May 4, 2017 16:05 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $4.73 Not disclosed
Disclosure

SEC source: 0001209191-17-029934 · doc4.xml · derivative · entry 1

RASTETTER WILLIAM H · CIK 0001205903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-01

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2017 Filed May 4, 2017 16:03 UTC
Nashat AmirDirector
GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $4.73 Not disclosed
Disclosure

SEC source: 0001209191-17-029933 · doc4.xml · derivative · entry 1

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-01

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2017 Filed May 4, 2017 16:02 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $4.73 Not disclosed
Disclosure

SEC source: 0001209191-17-029932 · doc4.xml · derivative · entry 1

MENDLEIN JOHN · CIK 0001238362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-01

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2017 Filed May 4, 2017 16:00 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $4.73 Not disclosed
Disclosure

SEC source: 0001209191-17-029931 · doc4.xml · derivative · entry 1

EPSTEIN ROBERT S · CIK 0001252004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-01

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2017 Filed May 4, 2017 15:58 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $4.73 Not disclosed
Disclosure

SEC source: 0001209191-17-029929 · doc4.xml · derivative · entry 1

Enyedy Mark J · CIK 0001586965 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-01

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
May 02, 2017 Filed May 4, 2017 15:56 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $4.73 Not disclosed
Disclosure

SEC source: 0001209191-17-029928 · doc4.xml · derivative · entry 1

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-01

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 16:03 UTC
Storgard ChrisChief Medical Officer
GrantStock Option (right to buy) · Derivative 150,000 Not disclosed Strike: $2.73 Not disclosed
Disclosure

SEC source: 0001209191-17-002631 · doc4.xml · derivative · entry 1

Storgard Chris · CIK 0001674703 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2027-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 21:03 UTC
Wolchko J ScottDirector · President and CEO
GrantStock Option (right to buy) · Derivative 250,000 Not disclosed Strike: $2.73 Not disclosed
Disclosure

SEC source: 0001209191-17-002633 · doc4.xml · derivative · entry 1

Wolchko J Scott · CIK 0001586893 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2027-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 21:03 UTC
TAHL CINDYGeneral Counsel and Secretary
GrantStock Option (right to buy) · Derivative 150,000 Not disclosed Strike: $2.73 Not disclosed
Disclosure

SEC source: 0001209191-17-002632 · doc4.xml · derivative · entry 1

TAHL CINDY · CIK 0001655472 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2027-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 21:02 UTC
Shoemaker Daniel DChief Scientific Officer
GrantStock Option (right to buy) · Derivative 150,000 Not disclosed Strike: $2.73 Not disclosed
Disclosure

SEC source: 0001209191-17-002630 · doc4.xml · derivative · entry 1

Shoemaker Daniel D · CIK 0001586892 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2027-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 21:02 UTC
ABBOT STEWARTChief Development Officer
GrantStock Option (right to buy) · Derivative 150,000 Not disclosed Strike: $2.73 Not disclosed
Disclosure

SEC source: 0001209191-17-002628 · doc4.xml · derivative · entry 1

ABBOT STEWART · CIK 0001655597 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2027-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.

Read SEC document
November 23, 2016 Filed Nov 28, 2016 15:46 UTC
Storgard ChrisChief Medical Officer
PurchaseCommon Stock 37,593 $2.66 $99,997.38
Disclosure

SEC source: 0001209191-16-152160 · doc4.xml · nonDerivative · entry 1

Storgard Chris · CIK 0001674703 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Storgard Family Trust, June 28, 2012

Disclosed balance after: 37,593

F1 · shares: Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.

F2 · ownership.nature: These shares are owned of record by The Storgard Family Trust, June 28, 2012 for which Chris M. Storgard and Melinda Storgard are co-trustees.

Read SEC document
November 23, 2016 Filed Nov 28, 2016 20:44 UTC PurchaseCommon Stock 375,939 $2.66 $999,997.74
Disclosure

SEC source: 0001209191-16-152157 · doc4.xml · nonDerivative · entry 1

RASTETTER WILLIAM H · CIK 0001205903 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Investment 2002 Trust dated 11/11/02

Disclosed balance after: 459,272

F1 · shares: Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.

F2 · ownership.nature: These shares are owned of record by The Investment 2002 Trust, dated November 11, 2002 for which William H. Rastetter is the sole trustee and owner.

Read SEC document
November 23, 2016 Filed Nov 28, 2016 20:42 UTC PurchaseCommon Stock 56,390 $2.66 $149,997.40
Disclosure

SEC source: 0001209191-16-152153 · doc4.xml · nonDerivative · entry 1

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,390

F1 · shares: Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.